<?xml version="1.0" encoding="UTF-8"?>
<p>In general, for the application of ABM for infectious diseases, there are several open questions for further research with respect to model validation and uncertainty analysis. For model validation a novel face validation technique where a human expert checks systematically what an agent perceives and how it reacts (immersive face validation) deserve closer attention [
 <xref rid="pone.0221564.ref052" ref-type="bibr">52</xref>]. For sensitivity analysis, testing the assumptions about human behavior [
 <xref rid="pone.0221564.ref041" ref-type="bibr">41</xref>] and doing a probabilistic sensitivity analysis within a reasonable time and taking into account correlation between parameters remain challenging [
 <xref rid="pone.0221564.ref038" ref-type="bibr">38</xref>].
</p>
